Three-Pronged attack tested for Tough-to-Treat liver tumors
NCT ID NCT06071052
Summary
This study tested a combination of three treatments for people with colorectal cancer that had spread to the liver and was no longer responding to standard chemotherapy. The goal was to see if using a targeted drug (regorafenib) along with two minimally invasive procedures that deliver chemotherapy directly to the liver could better control the cancer and help patients live longer. The study involved 21 patients who had already tried and failed other treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER METASTASIS COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
the first affiliated hospital, Sun-Yat sen university
Guangzhou, Guangdong, 510000, China
Conditions
Explore the condition pages connected to this study.